Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment

Exhaled nitric oxide (eNO) detects airway inflammation. Hyperbaric oxygen therapy (HBOT) is used for tissue hypoxia, but can cause lung damage. We measured eNO following inhalation of oxygen at different tensions and pressures. Methods. Part 1, eNO was measured before and after HBOT. Part 2, normal...

Full description

Saved in:
Bibliographic Details
Main Authors: Zudin A. Puthucheary, Jia Liu, Michael Bennett, Barbara Trytko, Sharron Chow, Paul S. Thomas
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/MI/2006/72620
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849402266401898496
author Zudin A. Puthucheary
Jia Liu
Michael Bennett
Barbara Trytko
Sharron Chow
Paul S. Thomas
author_facet Zudin A. Puthucheary
Jia Liu
Michael Bennett
Barbara Trytko
Sharron Chow
Paul S. Thomas
author_sort Zudin A. Puthucheary
collection DOAJ
description Exhaled nitric oxide (eNO) detects airway inflammation. Hyperbaric oxygen therapy (HBOT) is used for tissue hypoxia, but can cause lung damage. We measured eNO following inhalation of oxygen at different tensions and pressures. Methods. Part 1, eNO was measured before and after HBOT. Part 2, normal subjects breathed 40% oxygen. Results. Baseline eNO levels in patients prior to HBOT exposure were significantly higher than in normal subjects (P < .05). After HBOT, eNO significantly decreased in patients (15.4 ± 2.0 versus 4.4 ± 0.5 ppb, P < .001), but not in normal subjects, after either 100% O2 at increased pressure or 40% oxygen, 1 ATA. In an in vitro study, nitrate/nitrite release decreased after 90 minutes HBOT in airway epithelial (A549) cells. Conclusion. HBO exposure causes a fall in eNO. Inducible nitric oxide synthase (iNOS) may cause elevated eNO in patients secondary to inflammation, and inhibition of iNOS may be the mechanism of the reduction of eNO seen with HBOT.
format Article
id doaj-art-8b60bba7a459463cbce837fd22bcf800
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-8b60bba7a459463cbce837fd22bcf8002025-08-20T03:37:34ZengWileyMediators of Inflammation0962-93511466-18612006-01-01200610.1155/MI/2006/7262072620Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy EnvironmentZudin A. Puthucheary0Jia Liu1Michael Bennett2Barbara Trytko3Sharron Chow4Paul S. Thomas5UNSW and Department of Respiratory Medicine, Faculty of Medicine, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaUNSW and Department of Respiratory Medicine, Faculty of Medicine, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaHyperbaric Unit, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaHyperbaric Unit, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaUNSW and Department of Respiratory Medicine, Faculty of Medicine, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaUNSW and Department of Respiratory Medicine, Faculty of Medicine, Prince of Wales Hospital, Randwick 2031, NSW, AustraliaExhaled nitric oxide (eNO) detects airway inflammation. Hyperbaric oxygen therapy (HBOT) is used for tissue hypoxia, but can cause lung damage. We measured eNO following inhalation of oxygen at different tensions and pressures. Methods. Part 1, eNO was measured before and after HBOT. Part 2, normal subjects breathed 40% oxygen. Results. Baseline eNO levels in patients prior to HBOT exposure were significantly higher than in normal subjects (P < .05). After HBOT, eNO significantly decreased in patients (15.4 ± 2.0 versus 4.4 ± 0.5 ppb, P < .001), but not in normal subjects, after either 100% O2 at increased pressure or 40% oxygen, 1 ATA. In an in vitro study, nitrate/nitrite release decreased after 90 minutes HBOT in airway epithelial (A549) cells. Conclusion. HBO exposure causes a fall in eNO. Inducible nitric oxide synthase (iNOS) may cause elevated eNO in patients secondary to inflammation, and inhibition of iNOS may be the mechanism of the reduction of eNO seen with HBOT.http://dx.doi.org/10.1155/MI/2006/72620
spellingShingle Zudin A. Puthucheary
Jia Liu
Michael Bennett
Barbara Trytko
Sharron Chow
Paul S. Thomas
Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
Mediators of Inflammation
title Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
title_full Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
title_fullStr Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
title_full_unstemmed Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
title_short Exhaled Nitric Oxide is Decreased by Exposure to the Hyperbaric Oxygen Therapy Environment
title_sort exhaled nitric oxide is decreased by exposure to the hyperbaric oxygen therapy environment
url http://dx.doi.org/10.1155/MI/2006/72620
work_keys_str_mv AT zudinaputhucheary exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment
AT jialiu exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment
AT michaelbennett exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment
AT barbaratrytko exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment
AT sharronchow exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment
AT paulsthomas exhalednitricoxideisdecreasedbyexposuretothehyperbaricoxygentherapyenvironment